#1 Clinical Trials Search in Europe

Ciclesonide

This article explores the use of ciclesonide, a corticosteroid medication, in clinical trials for the treatment of asthma and allergic rhinitis. Ciclesonide has been studied in various formulations, including inhalers and nasal sprays, to evaluate its efficacy and safety in managing these respiratory conditions. The trials have investigated different dosages, administration methods, and patient populations to determine the optimal use of ciclesonide in clinical practice.

Table of Contents

What is Ciclesonide?

Ciclesonide is a medication that belongs to a class of drugs called corticosteroids. It is primarily used to treat respiratory conditions such as asthma and allergic rhinitis (hay fever). Ciclesonide is known by several brand names, including Alvesco for inhalation aerosol, Omnaris for nasal spray, and Zetonna for nasal aerosol[1].

What makes ciclesonide unique is that it’s a “prodrug.” This means that it becomes active only after it enters your body. When you inhale or spray ciclesonide, it gets converted into its active form (called des-ciclesonide) in your lungs or nasal passages. This special characteristic helps to reduce some of the side effects commonly associated with other corticosteroids[2].

What Conditions Does Ciclesonide Treat?

Ciclesonide is approved to treat several respiratory conditions:

  • Asthma: Ciclesonide is used to prevent and control asthma symptoms in adults and children. It helps reduce inflammation in the airways, making breathing easier[3].
  • Allergic Rhinitis: This includes both seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis (year-round allergies). Ciclesonide nasal sprays help relieve symptoms like sneezing, runny nose, and nasal congestion[4].
  • Exercise-Induced Bronchoconstriction: Some studies have investigated ciclesonide’s effectiveness in preventing asthma symptoms triggered by exercise[3].

How Does Ciclesonide Work?

Ciclesonide works by reducing inflammation in your airways. When you inhale or spray ciclesonide, it gets converted into its active form (des-ciclesonide) in your lungs or nasal passages. This active form then:

  • Decreases the production of substances that cause inflammation
  • Reduces swelling in the airways
  • Helps relax the muscles around the airways

By doing these things, ciclesonide helps to open up your airways, making it easier to breathe and reducing symptoms like wheezing, coughing, and shortness of breath[5].

Forms and Dosages of Ciclesonide

Ciclesonide comes in several forms:

  • Inhalation Aerosol (Alvesco): This is used for asthma treatment. Common doses range from 80 to 320 micrograms (mcg) per day, usually taken as one or two puffs twice daily[6].
  • Nasal Spray (Omnaris): Used for allergic rhinitis, the typical dose is 200 mcg once daily, given as two sprays in each nostril[4].
  • Nasal Aerosol (Zetonna): Another form for allergic rhinitis, usually dosed at 74 mcg once daily, given as one spray in each nostril[7].

Your doctor will prescribe the most appropriate form and dose for your condition.

Effectiveness of Ciclesonide

Clinical trials have shown ciclesonide to be effective in treating both asthma and allergic rhinitis:

  • For asthma, ciclesonide has been shown to improve lung function, reduce asthma symptoms, and decrease the need for rescue medications[6].
  • In allergic rhinitis, ciclesonide nasal sprays have been effective in reducing nasal symptoms like congestion, runny nose, and sneezing[4].
  • Some studies have also found ciclesonide to be helpful in preventing exercise-induced asthma symptoms[3].

It’s important to note that ciclesonide is a preventive medication. It works best when used regularly, even when you’re not experiencing symptoms.

Potential Side Effects

Ciclesonide is generally well-tolerated, but like all medications, it can cause side effects. Some potential side effects include:

  • Headache
  • Nose bleeds (with nasal sprays)
  • Throat irritation
  • Cough (with inhalers)

Serious side effects are rare but can include:

  • Increased risk of infections
  • Slowed growth in children (when used long-term)
  • Eye problems like glaucoma or cataracts (with long-term use)

Always discuss any side effects with your healthcare provider[7].

Use in Special Populations

Ciclesonide has been studied in various populations:

  • Children: Ciclesonide is approved for use in children as young as 6 years old for asthma treatment. However, growth should be monitored in children using corticosteroids long-term[1].
  • Pregnant Women: The safety of ciclesonide during pregnancy hasn’t been fully established. Always consult with your doctor if you’re pregnant or planning to become pregnant.
  • Elderly: No specific dose adjustments are typically needed for older adults, but they may be more sensitive to side effects.

Ongoing Research on Ciclesonide

Research on ciclesonide continues to explore its potential benefits:

  • A study is investigating the use of inhaled ciclesonide in premature infants at risk of developing bronchopulmonary dysplasia, a chronic lung condition[2].
  • Another study is looking at how ciclesonide affects airway responsiveness in people with asthma[8].

These ongoing studies may lead to new uses for ciclesonide in the future.

Aspect Details
Drug Name Ciclesonide
Conditions Studied Asthma, Seasonal Allergic Rhinitis (SAR), Perennial Allergic Rhinitis (PAR), Bronchopulmonary Dysplasia
Formulations Metered-dose inhaler (MDI), Nasal spray
Dosage Ranges 40 μg to 640 μg daily (varies by study and condition)
Primary Outcomes Changes in lung function (FEV1), Asthma symptom improvement, Nasal symptom score reduction, Asthma control (ACQ scores)
Safety Monitoring Adverse events, Vital signs, Physical examinations, Laboratory tests
Special Populations Children (4-12 years), Adults, Preterm infants
Study Designs Randomized, double-blind, placebo-controlled, parallel-group

FAQ

  • What is ciclesonide and how does it work? Ciclesonide is a corticosteroid medication used to treat asthma and allergic rhinitis. It works by reducing inflammation in the airways, which helps to alleviate symptoms such as wheezing, shortness of breath, and nasal congestion.
  • What conditions are being studied with ciclesonide in clinical trials? Clinical trials are investigating ciclesonide for the treatment of asthma, seasonal allergic rhinitis (SAR), perennial allergic rhinitis (PAR), and bronchopulmonary dysplasia in preterm infants.
  • How is ciclesonide administered in these trials? Ciclesonide is administered in various forms, including metered-dose inhalers (MDIs) for asthma and nasal sprays for allergic rhinitis. The dosages and frequency of administration vary depending on the specific trial and condition being studied.
  • What are some of the primary outcomes being measured in ciclesonide trials? Primary outcomes in ciclesonide trials include changes in lung function (such as FEV1), improvements in asthma symptoms, reduction in nasal symptom scores for allergic rhinitis, and assessment of overall asthma control using questionnaires like the Asthma Control Questionnaire (ACQ).
  • Are there any notable side effects or safety concerns with ciclesonide? While ciclesonide is generally well-tolerated, clinical trials are monitoring for potential side effects such as oral thrush, changes in blood glucose levels, effects on growth in children, and any other adverse events. Safety assessments include monitoring vital signs, physical examinations, and laboratory tests.

Ongoing Clinical Trials on Ciclesonide

  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1 1
    Investigated drugs:
    Germany

Glossary

  • Ciclesonide: A corticosteroid medication used to treat asthma and allergic rhinitis by reducing inflammation in the airways.
  • FEV1: Forced Expiratory Volume in one second, a measure of lung function used to assess the severity of airflow obstruction.
  • Metered-dose inhaler (MDI): A device that delivers a specific amount of medication to the lungs in the form of a short burst of aerosolized medicine that is usually self-administered by the patient via inhalation.
  • Allergic rhinitis: Inflammation of the nasal passages caused by an allergic reaction, resulting in symptoms such as sneezing, itching, nasal congestion, and runny nose.
  • Bronchopulmonary dysplasia: A chronic lung disease that affects premature infants, characterized by inflammation and scarring in the lungs.
  • Asthma Control Questionnaire (ACQ): A standardized tool used to measure the adequacy of asthma control and changes in asthma control over time.
  • Total Nasal Symptom Score (TNSS): A measure used in allergic rhinitis studies to assess the severity of nasal symptoms such as runny nose, itchy nose, sneezing, and nasal congestion.
  • Placebo: An inactive substance or treatment used in clinical trials as a control to compare against the effects of the active drug being studied.
  • Bronchospasm: A sudden constriction of the muscles in the walls of the bronchioles, causing difficulty in breathing.
  • Hyperglycemia: An abnormally high level of glucose in the blood, which is being monitored as a potential side effect in some ciclesonide trials.

References

  1. https://clinicaltrials.gov/study/NCT01550471
  2. https://clinicaltrials.gov/study/NCT06589245
  3. https://clinicaltrials.gov/study/NCT00525772
  4. https://clinicaltrials.gov/study/NCT02155881
  5. https://clinicaltrials.gov/study/NCT01147224
  6. https://clinicaltrials.gov/study/NCT01455194
  7. https://clinicaltrials.gov/study/NCT01654536
  8. https://clinicaltrials.gov/study/NCT03839433